Skip to Main Content

Paper Details

A meta-analysis approach for characterizing pan-cancer mechanisms of drug sensitivity in cell lines.
PLoS One
7
2014
AZD6244, Cancer, Cancer Cell Line, DNA, DNA damage repair, DNA damage repair genes, HDAC, Irinotecan, MAP/ERK kinases, MEK, PD-0325901, Panobinostat, STAT-1, TOP1, Topoisomerase 1, Topotecan, cancer, cancer cell lines, cancer lineages, cell lines, deficiency in, histone deacetylases, interferon, multi-drug resistance, multi-drug resistance (MDR) genes, patient, patients
Author NameAffiliation
Raunak ShresthaVancouver General Hospital, University of British Columbia
Alexander W WyattVancouver General Hospital
Anupama ReddyNovartis Pharmaceuticals
Joseph LehárNovartis Pharmaceuticals
Anna LapukVancouver General Hospital
Colin C CollinsVancouver General Hospital, the University of British Columbia
  • 1 - 6

Datasets

Release 1.2